{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:09:19Z","timestamp":1779314959240,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,9]]},"DOI":"10.7759\/cureus.62008","type":"journal-article","created":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T16:45:28Z","timestamp":1717951528000},"source":"Crossref","is-referenced-by-count":1,"title":["COVID-19 Infection and St-Elevation Myocardial Infarction: Lessons in Disease Management During a Pandemic"],"prefix":"10.7759","author":[{"given":"Anna","family":"Carmichael","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph T","family":"Hale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahnawaz","family":"Notta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tariq","family":"Haddadin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manar H","family":"Jbara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"WHO coronavirus (COVID-19) dashboard. (2023). Accessed. June 8, 2024: https:\/\/data.who.int\/dashboards\/covid19\/cases?n=c."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.07.022","article-title":"High thrombus burden in patients with COVID-19 presenting with ST-segment elevation myocardial infarction","volume":"76","author":"Choudry FA","year":"2020","unstructured":"Choudry FA, Hamshere SM, Rathod KS, et al.. High thrombus burden in patients with COVID-19 presenting with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2020, 76:1168-76. 10.1016\/j.jacc.2020.07.022","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30145-9","article-title":"Coagulation abnormalities and thrombosis in patients with COVID-19","volume":"7","author":"Levi M","year":"2020","unstructured":"Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020, 7:e438-40. 10.1016\/S2352-3026(20)30145-9","journal-title":"Lancet Haematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30151-4","article-title":"COVID-19 coagulopathy: an evolving story","volume":"7","author":"The Lancet Haematology","year":"2020","unstructured":"The Lancet Haematology. COVID-19 coagulopathy: an evolving story. Lancet Haematol. 2020, 7:e425. 10.1016\/S2352-3026(20)30151-4","journal-title":"Lancet Haematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.hfc.2022.08.007","article-title":"A review of ST-elevation myocardial infarction in patients with COVID-19","volume":"19","author":"Ghasemzadeh N","year":"2023","unstructured":"Ghasemzadeh N, Kim N, Amlani S, et al.. A review of ST-elevation myocardial infarction in patients with COVID-19. Heart Fail Clin. 2023, 19:197-204. 10.1016\/j.hfc.2022.08.007","journal-title":"Heart Fail Clin"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa106","article-title":"COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options","volume":"116","author":"Guzik TJ","year":"2020","unstructured":"Guzik TJ, Mohiddin SA, Dimarco A, et al.. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020, 116:1666-87. 10.1093\/cvr\/cvaa106","journal-title":"Cardiovasc Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.051828","article-title":"Microthrombi as a major cause of cardiac injury in COVID-19: a pathologic study","volume":"143","author":"Pellegrini D","year":"2021","unstructured":"Pellegrini D, Kawakami R, Guagliumi G, et al.. Microthrombi as a major cause of cardiac injury in COVID-19: a pathologic study. Circulation. 2021, 143:1031-42. 10.1161\/CIRCULATIONAHA.120.051828","journal-title":"Circulation"},{"key":"ref8","article-title":"Fuster & Hurst\u2019s The Heart (15th Edition)","author":"Fuster V","year":"2022","unstructured":"Fuster V, Narula J, Vaishnava P, et al.. Fuster & Hurst\u2019s The Heart (15th Edition). McGraw Hill, New York, NY; 2022."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.06.068","article-title":"Cardiac troponin for assessment of myocardial injury in COVID-19: JACC review topic of the week","volume":"76","author":"Sandoval Y","year":"2020","unstructured":"Sandoval Y, Januzzi JL Jr, Jaffe AS. Cardiac troponin for assessment of myocardial injury in COVID-19: JACC review topic of the week. J Am Coll Cardiol. 2020, 76:1244-58. 10.1016\/j.jacc.2020.06.068","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.33963\/KP.a2022.0072","article-title":"Specific characteristics of STEMI in COVID-19 patients and their practical implications","volume":"80","author":"Gitto M","year":"2022","unstructured":"Gitto M, Novelli L, Reimers B, Condorelli G, Stefanini GG. Specific characteristics of STEMI in COVID-19 patients and their practical implications. Kardiol Pol. 2022, 80:266-77. 10.33963\/KP.a2022.0072","journal-title":"Kardiol Pol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7326\/M22-3350","article-title":"Effect of thromboprophylaxis on clinical outcomes after COVID-19 hospitalization","volume":"176","author":"Wang TY","year":"2023","unstructured":"Wang TY, Wahed AS, Morris A, et al.. Effect of thromboprophylaxis on clinical outcomes after COVID-19 hospitalization. Ann Intern Med. 2023, 176:515-23. 10.7326\/M22-3350","journal-title":"Ann Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.02.041","article-title":"Randomized trial of anticoagulation strategies for noncritically ill patients hospitalized with COVID-19","volume":"81","author":"Stone GW","year":"2023","unstructured":"Stone GW, Farkouh ME, Lala A, et al.. Randomized trial of anticoagulation strategies for noncritically ill patients hospitalized with COVID-19. J Am Coll Cardiol. 2023, 81:1747-62. 10.1016\/j.jacc.2023.02.041","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1744302","article-title":"To anticoagulate or not to anticoagulate in COVID-19: lessons after 2 years","volume":"49","author":"Rizk JG","year":"2023","unstructured":"Rizk JG, Gupta A, Lazo JG Jr, Sardar P, Henry BM, Lavie CJ, Effron MB. To anticoagulate or not to anticoagulate in COVID-19: lessons after 2 years. Semin Thromb Hemost. 2023, 49:62-72. 10.1055\/s-0042-1744302","journal-title":"Semin Thromb Hemost"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01203-4","article-title":"Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial","volume":"397","author":"Lopes RD","year":"2021","unstructured":"Lopes RD, de Barros E Silva PG, Furtado RH, et al.. Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial. Lancet. 2021, 397:2253-63. 10.1016\/S0140-6736(21)01203-4","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2400","article-title":"Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial","volume":"375","author":"Sholzberg M","year":"2021","unstructured":"Sholzberg M, Tang GH, Rahhal H, et al.. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial. BMJ. 2021, 375:n2400. 10.1136\/bmj.n2400","journal-title":"BMJ"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/243825-covid-19-infection-and-st-elevation-myocardial-infarction-lessons-in-disease-management-during-a-pandemic","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T16:45:31Z","timestamp":1717951531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/243825-covid-19-infection-and-st-elevation-myocardial-infarction-lessons-in-disease-management-during-a-pandemic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,9]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.62008","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,9]]}}}